Abstract
The regulation of inflammatory mediators in the degenerating intervertebral disc (IVD) and corresponding ligamentum flavum (LF) is a topic of emerging interest. The study aimed to investigate the expression of a broad array of inflammatory mediators in the degenerated LF and IVD using a dog model of spontaneous degenerative disc disease (DDD) to determine potential treatment targets.
Methods
LF and IVD tissues were collected from 22 normal dogs (Pfirrmann grades I and II) and 18 dogs affected by DDD (Pfirrmann grades III and IV). A qPCR gene array was used to investigate the expression of 80 inflammatory genes for LF and IVD tissues, whereafter targets of interest were investigated in additional tissue samples using qPCR, western blot (WB), and immunohistochemistry.
Results
Tumor necrosis factor superfamily (TNFSF) signaling was identified as a regulated pathway in DDD, based on the significant regulation (n-fold ± SD) of various TNFSF members in the degenerated IVD, including nerve growth factor (NGF; −8 ± 10), CD40LG (464 ± 442), CD70 (341 ± 336), TNFSF Ligand 10 (9 ± 8), and RANKL/TNFSF Ligand 11 (85 ± 74). In contrast, TNFSF genes were not significantly affected in the degenerated LF compared to the control LF. Protein expression of NGF (WB) was significantly upregulated in both the degenerated LF (4.4 ± 0.5) and IVD (11.3 ± 5.6) compared to the control group. RANKL immunopositivity was significantly upregulated in advanced stages of degeneration (Thompson grades IV and V) in the nucleus pulposus and annulus fibrosus of the IVD, but not in the LF.
Conclusions
DDD involves a significant upregulation of various TNFSF members, with tissue-specific expression profiles in LF and IVD tissues. The differential involvement of TNFSF members within multiple spinal tissues from the same individual provides new insights into the inflammatory processes involved in DDD and may provide a basis to formulate hypotheses for the determination of potential treatment targets.
Original language | English |
---|---|
Article number | e1292 |
Pages (from-to) | 1-19 |
Number of pages | 19 |
Journal | JOR Spine |
Volume | 7 |
Issue number | 1 |
DOIs | |
Publication status | Published - Mar 2024 |
Bibliographical note
Publisher Copyright:© 2023 The Authors. JOR Spine published by Wiley Periodicals LLC on behalf of Orthopaedic Research Society.
Funding
This work was financially supported by Forschungskredit Postdoc, University of Zurich, Switzerland (Grant number FK14-053) and OPO Stiftung, Zurich, Switzerland, 2016. We would like to acknowledge the work of the Musculoskeletal Research Unit (MRSU; Salim Darwiche, Aymone Lenisa) for conducting the immunohistochemistry experiments and the Functional Genomics Center Zurich (FGCZ) of ETH Zurich and the University of Zurich for their support in conducting the genomics experiments. This work was financially supported by Forschungskredit Postdoc, University of Zurich, Switzerland (Grant number FK14‐053) and OPO Stiftung, Zurich, Switzerland, 2016. We would like to acknowledge the work of the Musculoskeletal Research Unit (MRSU; Salim Darwiche, Aymone Lenisa) for conducting the immunohistochemistry experiments and the Functional Genomics Center Zurich (FGCZ) of ETH Zurich and the University of Zurich for their support in conducting the genomics experiments.
Funders | Funder number |
---|---|
Musculoskeletal Research Unit | |
OPO-Stiftung | |
Eidgenössische Technische Hochschule Zürich | |
Universität Zürich | FK14‐053 |
Functional Genomics Center Zurich |
Keywords
- RANKL
- back pain
- degenerative disc disease
- dog
- inflammation
- nerve growth factor
- tumornecrosis factor superfamily